Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Trevena Inc (TRVN)
NASDAQ:TRVN
Trevena (TRVN) Stock Price & Analysis
1,220 Followers
TRVN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.30 - $1.35
Previous Close$0.42
Volume76.44K
Average Volume (3M)210.02K
Market Cap
$7.70M
Enterprise Value$2.39M
Total Cash (Recent Filing)$34.95M
Total Debt (Recent Filing)$29.64M
Price to Earnings (P/E)-0.2
Beta0.06
Next Earnings
Aug 08, 2024EPS Estimate
-$0.41Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.67
Shares Outstanding18,321,010
10 Day Avg. Volume76,265
30 Day Avg. Volume210,023
Standard Deviation0.27
R-Squared0.05
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)2.16
Price to Sales (P/S)5.79
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.53
Enterprise Value/Gross Profit-1.41
Enterprise Value/Ebitda-0.08
Forecast
1Y Price Target
$4.00Price Target Upside882.80% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Trevena News
PremiumCompany Announcements
Trevena Inc Unveils Updated Corporate Strategy Presentation
PremiumPre-Earnings
Is TRVN a Buy, Before Earnings?
PremiumCompany Announcements
Trevena Inc Elevates Barry Shin to Executive VP and CFOBulls Say, Bears Say
Bulls Say
Drug DevelopmentTRV045 continues to advance with successful formulation work to remove any food effect and favorable tolerability.
Financial HealthSufficient funds to support operations into the following year.
Strategic Business FocusSwitching focus to TRV045 is seen as the right business direction due to its potential in treating diabetic neuropathy pain and epilepsy.
Bears Say
Financial PerformanceOlinvyk sales remained disappointing at -$84K likely due to product returns.
Product SalesOlinvyk sales remained disappointing, which may lead to modest proceeds if it generates strategic interest.
Stock ValuationAnalyst reiterates Market Outperform rating, but lowers price target to $3 reflecting equity dilution.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
TRVN FAQ
What was Trevena Inc’s price range in the past 12 months?
Trevena Inc lowest stock price was $0.30 and its highest was $1.35 in the past 12 months.
What is Trevena Inc’s market cap?
Currently, no data Available
When is Trevena Inc’s upcoming earnings report date?
Trevena Inc’s upcoming earnings report date is Aug 08, 2024 which is in 84 days.
How were Trevena Inc’s earnings last quarter?
Trevena Inc released its earnings results on May 09, 2024. The company reported -$1.06 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.06.
Is Trevena Inc overvalued?
According to Wall Street analysts Trevena Inc’s price is currently Undervalued.
Does Trevena Inc pay dividends?
Trevena Inc does not currently pay dividends.
What is Trevena Inc’s EPS estimate?
Trevena Inc’s EPS estimate is -$0.41.
How many shares outstanding does Trevena Inc have?
Trevena Inc has 18,321,010 shares outstanding.
What happened to Trevena Inc’s price movement after its last earnings report?
Trevena Inc reported an EPS of -$1.06 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.326%.
Which hedge fund is a major shareholder of Trevena Inc?
Among the largest hedge funds holding Trevena Inc’s share is Harbourvest Partners Llc. It holds Trevena Inc’s shares valued at N/A.
---
Trevena Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.00 (882.80% Upside)
$4.00 (882.80% Upside)
Blogger Sentiment
Neutral
TRVN Sentiment 50%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 63.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 1.8%
Last 30 Days ▼ 1.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-64.40%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-18.69%
Trailing 12-Months
Company Description
Trevena Inc
Trevena, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of innovative treatment options that target and treat diseases affecting the central nervous system, or CNS. The company product pipeline consists of Olinvo, TRV250, and TRV734. Trevena was founded by Robert Joseph Lefkowitz, Scott DeWire, Howard A. Rockman, Jonathan Violin and Erin Whalen on November 9, 2007 and is headquartered in Chesterbrook, PA.
---
TRVN Earnings Call
Q3 2023
0:00 / 0:00
---
TRVN Stock 12 Month Forecast
Average Price Target
$4.00
▲(882.80% Upside)
Technical Analysis
Best Analysts Covering TRVN
1 Year
1 Year Success Rate
3/23 ratings generated profit
1 Year Average Return
-38.69%
reiterated a buy rating 2 days ago
Copying Jason Butler's trades and holding each position for 1 Year would result in 13.04% of your transactions generating a profit, with an average return of -38.69% per trade.
---